Insights
Search Results
Client Highlights
5.06.26
Wilson Sonsini Advises QuantWare on $178 Million Series B
On May 5, 2026, QuantWare, a leading industrial quantum processor company, announced a $178 million Series B equity fundraising following the announcement of VIO-40K™, a quantum processor architecture for 10,000 qubits, 100x larger than the state of the art today. New investors joining the round include Intel Capital, IQT, and ETF Partners, with participating existing investors including FORWARD.one and Invest-NL Deep Tech Fund, InnovationQuarter Capital, Ground State Ventures, and Graduate Ventures. The round was heavily oversubscribed and is the largest private round raised by a dedicated quantum processor company to date. Wilson Sonsini Goodrich & Rosati advised QuantWare on the transaction.
QuantWare is the only company that designs, fabricates, and integrates modular quantum processors on an open architecture at an industrial scale. The company is building KiloFab, the world’s largest dedicated quantum open architecture fab, increasing its production capacity by 20x to meet strong global customer demand.
The Wilson Sonsini team that advised QuantWare on the financing included:
Corporate
Daniel Glazer
Michael Labriola
Ashmi Bhagani
Elisa Sielski
Michael Soud
Daniel Jordan
Henry Oates
QuantWare is the only company that designs, fabricates, and integrates modular quantum processors on an open architecture at an industrial scale. The company is building KiloFab, the world’s largest dedicated quantum open architecture fab, increasing its production capacity by 20x to meet strong global customer demand.
The Wilson Sonsini team that advised QuantWare on the financing included:
Corporate
Daniel Glazer
Michael Labriola
Ashmi Bhagani
Elisa Sielski
Michael Soud
Daniel Jordan
Henry Oates
Client Highlights
12.15.25
Wilson Sonsini Advises PolyAI on $86 Million Series D Financing
On December 15, 2025, PolyAI, a leader in enterprise conversational AI, announced it has raised $86 million in Series D funding, co-led by Georgian, Hedosophia, and Khosla Ventures. Additional investors include NVentures, British Business Bank, Citi Ventures, Squarepoint Ventures, Sands Capital, Zendesk Ventures, and Point72 Ventures. Wilson Sonsini Goodrich & Rosati advised PolyAI on the transaction.
Client Highlights
12.04.25
Wilson Sonsini Advises Radical Health on $5 Million Pre-Seed Funding as Company Emerges from Stealth
On December 4, 2025, Radical Health emerged from stealth and announced a $5 million Pre-Seed funding round led by Khosla Ventures. Wilson Sonsini Goodrich & Rosati advised Radical Health on the transaction.
Client Highlights
12.03.24
Wilson Sonsini Advises 9fin on $50 Million Funding to Invest in AI and Pursue U.S. Expansion
On December 2, 2024, 9fin, the AI-powered analytics platform for debt capital markets, announced it has raised $50 million in a Series B round led by Highland Europe, with participation from existing investors Spark Capital, Redalpine, Seedcamp, 500 Startups, and Ilavska Vuillermoz Capital. The new funding will enable 9fin to invest further in its market-leading AI technology, grow its analytics team, and accelerate its expansion in the U.S.
Client Advisories
11.13.24
“You Don’t Have to Go Home, but You Can’t Stay Here”: Founder Exits (Part 1)
Venture-stage investors make their investment in the people of a business as much as they do the idea and the operations. The drive, the know-how, the effort, and the vision of the founders are typically what attract first investment. However, what happens when the founder then leaves either by their own decision or at the request of the shareholders of the business?